Home » MHRA to Streamline OTC Reclassifications, Improve Communications With Sponsors
MHRA to Streamline OTC Reclassifications, Improve Communications With Sponsors
April 6, 2012
A Medicines and Healthcare products Regulatory Agency work group is developing proposals for streamlining the UK’s over-the-counter drug reclassification process, and plans to release updated guidance on the subject later this year, according to an MHRA report. Includes the full text of MHRA's Fifth Report on Better Regulation of Medicines Initiative.
To View This Article:
Subscribe To International Pharmaceutical Regulatory Monitor